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Abstract
Background: During the first trimester of pregnancy, HIV-1 mother-to-child transmission is relatively rare despite the
permissivity of placental cells to cell-to-cell HIV-1 infection. The placenta interacts directly with maternal uterine cells
(decidual cells) but the physiological role of the decidua in the control of HIV-1 transmission and whether decidua could be
a source of infected cells is unknown.
Methodology/Principal Findings: To answer to this question, decidual mononuclear cells were exposed to HIV-1 in vitro.
Decidual cells were shown to be more susceptible to infection by an R5 HIV-1, as compared to an X4 HIV-1. Infected cells
were identified by flow cytometry analysis. The results showed that CD14
+ cells were the main targets of HIV-1 infection in
the decidua. These infected CD14
+ cells expressed DC-SIGN, CD11b, CD11c, the Fc gamma receptor CD16, CD32 and CD64,
classical MHC class-I and class-II and maturation and activation molecules CD83, CD80 and CD86. The permissivity of
decidual tissue was also evaluated by histoculture. Decidual tissue was not infected by X4 HIV-1 but was permissive to R5
HIV-1. Different profiles of infection were observed depending on tissue localization.
Conclusions/Significance: The presence of HIV-1 target cells in the decidua in vitro and the low rate of in utero mother-to-
child transmission during the first trimester of pregnancy suggest that a natural control occurs in vivo limiting cell-to-cell
infection of the placenta and consequently infection of the fetus.
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Introduction
During pregnancy, mother-to-child transmission (MTCT) of
HIV-1 is relatively rare. Indeed, most MTCT cases occur during
delivery and in the postpartum period via breastfeeding [1,2]. Even
in the absence of antiretroviral therapy, 90% of fetuses are
protected against in utero transmission. Most in utero transmissions
occur during the third trimester of pregnancy [2]. This suggests
that a natural control of MTCT occurs particularly during the first
months of pregnancy. In the uterine cavity the placenta acts as a
physical barrier between the fetus and the mucosa of the uterine
wall (also known as the decidua) [3]. We and others have shown
that the placenta plays a role in controlling HIV-1 transmission,
since the trophoblast cells, which form the outer layer of the
placenta, are not permissive to cell-free HIV-1 virus [4–6].
However trophoblast cells can be infected via cell-to-cell contact
by HIV-1 infected cells [7,8]. Cytokines (such as TNFa and IL-8
among others), and chemokines (such as CCL5 and LIF) present in
the placental environment regulate this route of infection [8,9].
Primary contact of trophoblast cells during pregnancy is mainly
with decidual cells during the first trimester and with maternal
blood cells thereafter [10]. Therefore the rarity of MTCT during
the first trimester might be explained either by the absence of
HIV-1 target cells in the decidua, or, if target cells are present, by
a natural control of viral transmission occurring within the
decidual tissue.
In the first trimester of pregnancy, decidual tissue is defined by
localization and function: the decidua basalis is localized at the
implantation site in close contact with the placenta, the decidua
parietalis lines the rest of the uterine wall, and the decidua
capsularis surrounds the conceptus [11]. The immune cells of the
decidua are composed of a high number of natural killer (dNK)
cells (which have a different phenotype and functions than their
blood counterparts), antigen presenting cells (dAPCs), some
regulatory T lymphocytes and a very small percentage of other
innate immunity cells such as NKT cells or cd T lymphocytes
[12]. From the beginning of pregnancy these immune cells
regulate the balance between inflammatory events required for
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5971placental invasion and angiogenesis [13,14] and anti-inflammatory
reactions needed for fetus survival [15]. These events are
dependent on cell-to-cell interactions between immune cells and
trophoblast cells.
The main objectives of this study were to investigate the
permissivity of the decidual cells to cell-free HIV-1 and to identify
potential HIV-1 target cells. Since MTCT events are rare during
the first trimester of pregnancy, the presence of target cells within
the decidua would strongly suggest that a first step of control occurs
in vivo to limit the dissemination of the virus from infected decidual
cells to the trophoblast. We focused ourstudy mainlyon thedecidua
basalis due to the direct contact of this tissue with the trophoblast.
Results
The decidual CD14
+ cells constitute potential targets of
HIV-1 infection
To identify potential cellular targets of HIV-1, mononuclear
cells were isolated from decidua basalis tissue and infected with
HIV-1BaL (R5) or HIV-1LAI (X4). Decidual leukocyte population
was composed by dNK cells (mean 64.48%, +/28.81 SD), CD14
+
dAPC (mean 20.92%, +/26.29 SD), CD4
+/CD3
+T lymphocytes
(mean 4.74%, +/21.82 SD) and non-CD4 CD3
+ T lymphocytes
(mean 6.64%, +/22.99 SD) (n=12). Viral infection was
monitored by the amount of the viral core p24 antigen in
supernatant over time (Fig. 1A). Viral replication of the HIV-1BaL
strain in decidual mononuclear cells was higher than in the HIV-
1LAI infection. The mean p24 antigen production in HIV-1LAI
infected cell supernatant was more than 35 fold lower than the one
observed in HIV-1BaL infected cell supernatant. Flow cytometry
analyses of these cells were performed at day 11 post-infection
when viral production was still increasing in vitro. Infected cells
were identified with an anti-p24 antigen antibody in the leukocyte
population (CD45
+ cells) and were characterized with anti-CD14,
anti-CD3 and anti-CD56 monoclonal antibodies. Flow cytometry
analysis showed that CD14
+ cells are the main targets of HIV-1
infection in this system (6,09%) (Fig. 1B). CD14
+ cells were
infected with HIV-1BaL (13,7%) and poorly infected by HIV-1LAI
(0,69%) (Fig. 1C). CD3
+ lymphocytes were poorly infected with
HIV-1BaL (0,75%), infection by HIV-1LAI was higher (5,51%)
(Fig. 1C). However HIV-1LAI infected CD3
+ cells constituted a
small percentage of the leukocytes population (0,76%) compared
to HIV-1BaL infected CD14
+ cells (6,09%) (data not shown). Flow
cytometry analyses also showed that no detectable intracellular
p24 was found in CD56
+ NK cells neither with HIV-1BaL nor with
HIV-1LAI (Fig. 1C). These data are representative of analysis from
nine different donors. Since the highest percentage of p24
+ cells is
detected in HIV-1BaL infected CD14
+ cells, we can conclude that
the CD14
+ cells are the main target of HIV-1BaL infection.
Moreover, decidual cells are more susceptible to HIV-1BaL
infection than HIV-1LAI as shown by the frequency of p24
+ cells.
To determine whether the isolated decidual CD14
+ cells could
be permissive to HIV-1, they were purified from HIV-1 negative
decidual tissue with magnetic beads and subsequently infected. As
shown in Figure 2, decidual CD14
+ cells were susceptible to
infection by HIV-1BaL (ranging from 1700 to 6280 pg p24 Ag/
ml), but were not permissive to HIV-1LAI (max=150 pg p24 Ag/
ml). However, the amount of p24 antigen detected in decidual
CD14
+ cells culture supernatant infected with HIV-1BaL was
approximately 35 fold lower than the amount detected in culture
supernatant of peripheral CD14
+ macrophages (obtained as
previously described [16]) (data not shown). These results indicate
that decidual CD14
+ cells were permissive to HIV-1BaL but to a
lower extent than peripheral blood macrophages.
Phenotypic characterization of HIV-1 infected decidual
CD14
+ cells
To characterize the phenotype of the infected decidual CD14
+
cells, flow cytometry analyses were performed on infected decidual
mononuclear cells at day 11 post infection. We observed that
infected decidual CD14
+ are CD11b
+, CD11c
+ and DC-SIGN
+
(Fig. 3A). They also expressed the co-stimulation markers CD80
and CD86, and the maturation marker CD83 at a lower level.
They expressed high levels of Fc gamma receptors CD16
(FCcRIII), CD32 (FCcRII) and CD64 (FCcRI); and the Fc alpha
receptor CD89 (Fig. 3C). As expected, down regulation of CD4
was observed on infected cell surface but HLA-DR and HLA-ABC
remained highly expressed. Infected CD14
+ cells all expressed
CCR5, the R5 HIV-1 co-receptor and at a lower level CXCR4,
the X4 HIV-1 co-receptor (Fig. 3B). These results indicate that
infected decidual CD14
+ cells express cell surface molecule that
are used as markers to define dendritic cells and macrophages.
Decidual histocultures are permissive to R5 HIV-1BaL
To evaluate the permissivity of the decidual tissue to HIV-1
infection, the histoculture model [17] was adapted to the decidua
basalis (DB). The morphology of the tissue sections at different
time points showed that decidual tissue does not display major
structural alterations before day 18 (Fig. S1). Viral infection was
monitored by the amount of the viral core p24 antigen in
supernatant over time (Fig. 4A). No consistent productive HIV-1
infection was observed in DB tissue when HIV-1LAI was used for
infection. Moreover no productive infection was observed even
with a 10 fold higher viral exposure (data not shown). Conversely,
DB tissue was infected by HIV-1BaL with production level of p24
antigen ranging from 500 to 2000 pg/ml.
To confirm the phenotype of the infected cells in situ in DB
histocultures, double immunohistochemistry staining was per-
formed on infected tissue sections. As shown in Figure 4B, infected
cells co-expressing the CD14 surface marker and the intracellular
p24 antigen were found in the decidual tissue.
As decidual immune populations are known to be different
depending on the localization of the tissue, we also evaluated the
permissivity of decidua parietalis (DP) tissue to HIV-1 (Fig. 4C). As
was observed for DB tissue, no productive infection was detected
with HIV-1LAI in DP histoculture supernatant. This tissue was
permissive to infection by HIV-1BaL, but different infection profiles
were observed when DP and DB infected histocultures were
compared. We observed a higher production level of p24 antigen in
DP histocultures with a maximum viral production around day 14.
Since different profiles of infection were shown between the
tissues, both DB and DP histocultures were analyzed by
immunohistochemistry at Day 0 (Fig. 4D) to evaluate the
percentage of the main leukocyte populations in the tissue. As
expected, high numbers of decidual NK cells (dNK) (CD56
+ cells),
and decidual antigen presenting cells (CD14
+ cells) were present in
both decidual tissue explants. A higher proportion of dNK was
found in the DB (median 43.53%, +/212.68 SD) than in the DP
(median 13.95%, +/29.3 SD) (p=0.001). CD14
+ cells also
constituted a major population in both tissue types (median in
DB 44.85%, +/27.29 SD and median in DP 42.54%, +/217.93
SD). A high proportion of HLA class II–expressing cells (median
DP 60.13% and DB 62.93%) and a low number of CD3
+ cells
(median DP 1.52% and DB 4.44%) were also observed in
histocultures. These experiments demonstrate that DB and DP
contain the same proportion of CD14
+ cells while differences in
infection profile were observed.
Taken together, these results showed that decidua could be
permissive to HIV-1BaL both at cellular and tissue level and that
Human Decidua and HIV-1
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5971Figure 1. Flow cytometry analyses of decidual infected cells. Isolated mononuclear cells of decidua basalis were infected with HIV-1BaL (R5)
and HIV-1LAI (X4) at 10
23 MOI. (A) Results are expressed in pg/ml of HIV-1 p24 viral core antigen measured by ELISA during the time course
experiment and represents the mean of p24 antigen detection in supernatant from twelve different donors. (B) Decidual cells were analyzed at 11
days post infection. Cells were gated on the leukocyte population (CD45
+) and characterized by expression of CD14 and p24 antigen markers. (C) To
evaluate the level of infection in each type of leukocytes, cells were also gated on CD14
+ cells (top), CD3
+ cells (middle) and CD56
+ cells (bottom).
Each pink gate shows the p24 antigen positive cells. Pink gates also determine the background for non-infected condition. Flow cytometry pictures (B
and C) show a representative of nine different donors.
doi:10.1371/journal.pone.0005971.g001
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+ cells were the main HIV-1BaL target in vitro
and in situ in histoculture.
Discussion
Several studies have shown the roles of immune cell populations
of the decidua (human uterine mucosa during pregnancy) in early
pregnancy events. Indeed, fetus tolerance involves dAPCs [18,19]
and decidual T regulatory lymphocytes [20], the dNK cells are
crucial for angiogenesis [21,22] and trophoblast invasion [13,23].
These immune cells also have an important role in the fetus
implantation [23]. In contrast, their role in the control of viral
transmission remains to be defined, particularly question of the
permissivity of these mucosal cells to HIV-1 infection. Here we
report for the first time that decidual mucosa and decidual
mononuclear cells are permissive to HIV-1 ex vivo. We observed
consistent infection with an HIV-1BaL strain (R5) but poor
infection with an HIV-1LAI strain (X4), demonstrating that these
cells were permissive mainly to R5 virus.
Flow cytometry analyses showed that T lymphocytes are
permissive to HIV-1LAI. However this population represents a
small proportion of decidual leukocytes and HIV-1LAI infection is
poor or undetectable in the mononuclear cells or at the tissue level
when compared to HIV-1BaL infection. The sensitivity of ELISA
assays and the influence of the cytokine environment could also
explain the detection of infected HIV-1LAI CD14
+ cells by flow
cytometry but the lack of detectable p24 production by HIV-1LAI
infected purified decidual CD14
+ cells and histocultures.
We identified that the main target cells for R5 HIV-1 in the
decidua are CD14
+ cells. In decidual tissue, the CD14 molecule is
expressed by the antigen presenting cell populations, which are
mostly macrophages and dendritic cells [24]. Phenotypic charac-
terization of decidual dendritic cells remains a topic of debate. In
some reports, dendritic cells are defined by the absence of lineage
antigens including the CD14 molecule [25]; in other reports these
cells express the CD14 receptor [19]. Here, we report that the
main HIV-1 target cells bear markers of both DC and
macrophages, which are usually used to distinguish these types
of cells in the peripheral blood. According to a recent study [26],
the decidual CD14
+ cells that we characterize as CD11b
+,
CD11c
+, DC-SIGN
+, CD16
+, CD32
+, CD64
+, HLA-DR
+,
HLA-ABC
+, CD4
+, CD80
+, CD86
+/2 and CD83
+/2 cells could
be Alternatively Activated M2 Macrophages [27]. These types of
macrophages are known to possess immunoregulative and tissue
remodeling functions [27] that are crucial at the materno-fetal
interface [28]. Cells with this same phenotype are also found in the
thymus but are described as dendritic cells [29]. These thymic DC
are permissive to HIV-1 R5 but not to HIV-1 X4 infection [30].
We also show that purified decidual CD14
+ cells replicate the
R5 virus HIV-1BaL, but to a lower level than peripheral blood
macrophages. This difference of replication level could be due to
the nature of decidual CD14
+ cells. A recent study has shown that
the polarization of M1 and M2a macrophages is associated with a
reduced capacity to support productive R5 HIV-1 infection [31].
As M2 macrophages are heterogenous [27] and HIV-1 infected
decidual CD14
+ cells bear macrophage and DC markers, further
investigation of the function and the phenotype of infected
decidual CD14
+ cells is required.
The presence of HIV-1 target cells in the decidua indicates that
a natural control might occur in vivo since mother-to-child
transmission events are rare during the first trimester of
pregnancy. Decidual CD14
+ cells, which are the main decidual
targets of HIV-1 R5 infection, are present in similar numbers in
the decidua basalis (DB) and in the decidua parietalis (DP). This
suggests that the number of target cells for HIV-1 infection is
comparable between DP and DB. However we observed different
profiles of productive viral infection between the two tissue types of
decidua, and a higher production of virus was observed in DP
infection compared to DB infection. As the number of target cells
is comparable in both tissues, the different infection profiles
suggest that there may be a limitation of HIV-1 R5 infection in the
decidua basalis. The lack of detection of HIV-1 X4 productive
infection could also be due to a control at the decidua level. Even if
the placenta has been shown to be an efficient barrier against
HIV-1 transmission by several non-exclusive mechanisms, a first
level of control might occur in the decidua to limit the
dissemination of the virus that could be transmitted by cell-to-
cell contact from infected decidual cells to the trophoblast cells of
the placenta [4]. Several mechanisms of control may be involved;
including maternal innate immunity. Scott-Algara et al observed
an activating phenotype of peripheral blood NK cells in HIV-1
exposed but uninfected patients [32], suggesting a protective role
of activated NK cells in HIV-1 infection. Other studies recently
showed a control of HIV-1 replication in dendritic cells mediated
by peripheral blood NK cells [33]. The activation phenotype of
dNK cells [22,34] suggests a role for these cells in the control of
HIV-1 infection within the decidua. Furthermore, at the materno-
fetal interface, a subtle balance of pro- and anti-inflammatory
cytokine secretion is required for the invasion of the placenta and
the maintenance of pregnancy [15]. We, and others [8,9], have
Figure 2. Infection of purified decidual CD14
+ cells. Purified decidual CD14
+ cells were infected by HIV-1BaL (R5) and HIV-1LAI (X4) strains
(10
23 MOI), and cultured up to 21 days. Infections were monitored by p24 antigen quantification over the course of the experiment. Each line
represents a separate donor. CD14
+ cells were purified from deciduas from at least three different donors.
doi:10.1371/journal.pone.0005971.g002
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CCL-5) or enhance (TNF-a, IL-8) the passage of the virus through
the placental barrier. They might also play a role in the control of
viral dissemination within the decidua.
The role of decidual immune cells in the control of mother-to-
child transmission of pathogens is relatively uncharacterized.
Previous reports on this subject describe interactions between
decidual immune cells (dAPCs) and Cytomegalovirus [35] or
between Listeria monocytogenes and dNK cells [36] or dAPCs [37].
Here, for the first time, we demonstrate the susceptibility of
decidual mucosa to HIV-1 infection in isolated mononuclear cells
as well as at the tissue level. The identification of HIV-1 decidual
target cells, the description of different permissivity to X4 and R5
virus, and the fact that the risk of mother-to-child transmission is
very low during the first trimester of pregnancy underline that the
materno-fetal interface is a very relevant model to study the
mechanism of natural protection against HIV-1 transmission at a
mucosal level.
Materials and Methods
Ethics statement
All women provided their written informed consent. The study
was approved by the ethics committee of the Ho ˆtel Dieu (Paris,
France), the Assistance Publique des Ho ˆpitaux de Paris (nu VAL/
2006/06-41/01) and the biomedical research committee of the
Institut Pasteur, Paris, France (nu RBM/2005.024).
Human decidual tissue collection
Decidual tissue samples were obtained from healthy women
undergoing voluntary pregnancy termination at the first trimester
of pregnancy (6–10 weeks) at Antoine Be ´cle `re Hospital, Clamart,
France and Tenon Hospital, Paris, France.
Decidua parietalis and decidua basalis were isolated from the
other tissues collected and washed with RPMI 1640 Glutamax
medium (Gibco, Invitrogen, Cergy Pontoise, France) supplement-
ed with 10% of foetal calf serum to eliminate blood and placental
contaminants.
HIV-1 isolates
Infections were performed with HIV-1 prototype isolates: BaL
(R5) which use CCR5 as entry co-receptor and LAI (X4) which
use CXCR4 as entry co-receptor. Viral isolates were amplified on
PHA-stimulated PBMC from two blood donors for 10 days.
PBMC cultures were maintained in RPMI 1640 Glutamax (Gibco)
supplemented with 10% of foetal calf serum, penicillin, strepto-
mycin and 100 U/ml of recombinant Interleukin-2 (Chiron,
Netherlands). Viral isolates were concentrated by centrifugation
on Vivaspin 100,000 Kda columns (Sartorius, Palaiseau, France)
at 14006g for 40 minutes. The tropism of viral isolates was
confirmed by infection of U87-CD4, U87-CD4/CCR5 and U87-
CD4/CXCR4 cells as previously described [38].
Antibodies
The antibodies used for flow cytometry and immunohistochem-
istry experiments are listed in Table 1.
Decidual histocultures
Decidual tissues (parietalis or basalis) were cut in 0.3 cm
2 pieces
and placed on collagen sponge gels (Pfizer, Paris, France) in
1.5 ml/well/sponge/piece of rich culture media containing Ham
F12: DMEM glutamax (V:V) (Gibco) supplemented with 15% of
foetal calf serum (PAA, Les Mureaux, France), penicillin (0.1 U/l)
and streptomycin (1610
28 g/l) (Gibco). Histocultures were
cultured for 21 days.
Isolation of decidual mononuclear cells
Freshly isolated decidual basalis tissue was cut into small fragments
a n dd i g e s t e df o r1h o u ra t3 7 uC under agitation in PBS (Gibco) with
1 mg/ml collagenase IV (Sigma, St Quentin Fallavier, France) and
50 U/ml recombinant DNase I (Roche, Meylan, France). The cell
suspension was filtered through 100, 70 and 40 mm sterile nylon cell
strainer successively (BD Biosciences, Le pont de Claix, France). The
Figure 3. Phenotypic characterization of infected decidual
CD14
+ cells. Isolated mononuclear cells from decidua basalis were
infected with HIV-1BaL (R5) at 10
23 MOI. Cells were analyzed 11 days
post infection. Cells were gated on leukocyte population (CD45
+) and
CD14
+ cells in non-infected cells or CD14
+/p24
+ cells in infected cells.
Results are represented in percentage of expression in CD14
+ cells
(purple bars) or CD14
+/p24
+ infected cells (checkered bars). Analyses of
decidual cells from nine different donors are represented with standard
error of the mean as error bars. (A) Expression of DC-SIGN, myeloid
markers CD11b and CD11c, maturation marker CD83 and activation
markers CD80 and CD86 were evaluated. (B) MHC-II and classical MHC-I
molecules, CD4 HIV-1 receptor and HIV-1 co-receptors of entry
expression were also measured. (C) Expression of Fc receptors.
doi:10.1371/journal.pone.0005971.g003
Human Decidua and HIV-1
PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5971Figure 4. Infection of decidua basalis and decidua parietalis histocultures. (A) Histocultures of decidua basalis were infected with HIV-1BaL
(R5) (left) and HIV-1LAI (X4) (right) virus at 1,800 TCID50/explant and cultured for 21 days following extensive washes. Each line represents a separate
donor. Results are expressed in pg/ml of p24 antigen measured by ELISA. At least three different deciduas were tested for each series of infection. (B)
Infected cells were identified and phenotyped on a decidua basalis section at day 10 post infection by HIV-1BaL. Frozen sections were stained with
anti-CD14 (left) (brown cells) and anti-p24 antigen (middle) (red cells). Infected cells were characterized by co-expression of the two markers (right).
Images were taken at6600 magnification and black scale line represents 10 mm length. (C) Histocultures of decidua parietalis were infected with HIV-
1BaL (left) and HIV-1LAI (right) HIV-1 with the same conditions of histocultures of decidua basalis. (D) Proportion of the main leukocytes population was
evaluated by immunostaining in decidua parietalis and decidua basalis histocultures at day 0. CD56
+, CD14
+, MHC-II
+ and CD3
+ cells were quantified
on tissue sections from at least 3 different deciduas. Minimums of 500 cells were evaluated on each decidua.
doi:10.1371/journal.pone.0005971.g004
Human Decidua and HIV-1
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Separation Medium (PAA) and cultured in the rich culture media
Ham F12: DMEM glutamax. Positive selection of CD14
+ cells was
performed using anti-CD14 magnetic beads (Miltenyi, Paris, France)
as recommended by the manufacturer.
HIV-1 infection of decidual histocultures
Explants of decidua parietalis and decidua basalis were
incubated overnight with the different HIV-1 isolates or mock
infected PBMC supernatants, at 1,800 TCID50 (optimized viral
dose) per explant except where indicated. Explants were then
washed 3 times and placed on collagen sponge gels for 21 days in
1.5 ml culture medium/well/sponge/piece. Culture supernatants
were harvested and fresh medium added to each well every 3–4
days. HIV-1 p24 antigen was quantified in the culture superna-
tants by ELISA (Zeptometrix, Gentaur). Experiments were
performed in triplicate and for each virus, decidua from at least
3 different donors were tested.
In some experiments, decidual tissues were also collected at
different time points and snap-frozen in Tissue-Tek for immuno-
histochemistry.
HIV-1 infection of isolated decidual mononuclear cells
and of purified CD14 positive cells
Isolated decidual mononuclear cells were incubated 2 hours
with HIV-1 isolates at 10
23 MOI or mock supernatant. Cells were
washed 3 times and cultured at 10
6 cells/ml. Cells were analysed
by flow cytometry at different time points. Infected cells were
stained for surface markers and subsequently fixed with 1%
paraformaldehyde solution (EMS, Hatfield, USA). For intracellu-
lar staining of p24 antigen, cells were permeabilized using
IntraPrep reagent (Beckman Coulter) according to manufacturer’s
instructions. The antibodies used for the experiments are shown in
Table 1. Flow cytometry analysis was performed using LSRII 2-
Blue 2-Violet 3-Red 5-Yelgr lasers configuration (BD Biosciences),
using Diva (BD Biosciences) and FlowJo 8.8.5 (Tristar) software.
At least 1000 events in p24
+ gate were analysed in each test.
Immunohistochemistry
Decidual sections were obtained by embedding decidual tissue (at
different culture time points) in Tissue-Tek (Sakura, Gentaur, Paris,
France) and snap-frozen in an isopentane/liquid nitrogen bath.
Frozen Tissue-Tek blocks were cut with a cryostat and frozen
Table 1.
Abs anti- Species/clone Manufacturer use
CD14 purified Mouse/RMO52 Beckman Coulter IHC*
CD14-Pacific Blue Mouse/M5E2 BD FLC*
CD3-PE-Texas Red Mouse/UCHT1 Beckman Coulter FLC
CD45-Amcyan Mouse/2D1 BD FLC
CD56-Alexa fluor 700 Mouse/B159 BD FLC
DC-SIGN-PE Mouse/120507 R&D FLC
CD11b-APC-Cy7 Mouse/ICRF44 BD FLC
CD11c-PE-Cy7 Mouse/3.9 eBioscience FLC
CD80-PE Mouse/L307.4 BD FLC
CD83-APC Mouse/HB15e BD FLC
CD86-APC Mouse/2331 BD FLC
CD16-PE-Cy5 Mouse/3G8 Beckman Coulter FLC
CD32-APC Mouse/FL18.26 BD FLC
CD64-PE-Cy5 Mouse/22 Beckman Coulter FLC
CD89-PE Mouse/A59 BD FLC
HLA-DR-PE Mouse/Immu357 Beckman Coulter FLC
HLA-ABC-PE-Cy5 Mouse/W6/32 eBioscience FLC
CD4-PE-Cy7 Mouse/SK3 BD FLC
CXCR4-APC Mouse/12G5 BD FLC
CCR5-APC-Cy7 Mouse/2D7 BD FLC
p24-FITC Mouse/KC57 Beckman Coulter FLC
CD3 purified Mouse/F7.2.38 Dako IHC
CD56 purified Mouse/N901 Beckman Coulter IHC
MHC-II purified Mouse/CR3/43 Dako IHC
p24 (HIV-1 core antigen) Goat/polyclonal Abcam IHC
Biotin labelled donkey anti-goat Donkey/polyclonal Abcam IHC
HRP polymer labelled Goat anti-mouse Dako IHC
Isotype matched Ig controls Mouse Beckman Coulter FLC, IHC
*FLC: Flow cytometry, IHC: Immunohistochemistry.
doi:10.1371/journal.pone.0005971.t001
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(Dako, Trappes, France). To evaluate the immune cell population
and identify infected cells, tissue sections were double stained for
HIV-1 core p24 antigen (goat antibody) and different surface
markers (mouse antibody) described in Table 1. Endogenous
peroxidase and alkaline phophatase (AP) were blocked for 10
minutes by addition of hydrogen peroxide and levamisol (Dako).
Surface markers were visualized using the Envision+ dual link
system (Dako) and Histogreen (Abcys, Paris, France) as a peroxidase
substrate. HIV-1 core antigen was visualized using biotin-
streptavidin-alkaline phosphatase complex and Vector Red (Abcys),
as an AP substrate. Tissue sections were counterstained with
haematoxylin(Labonord,templars,France), mounted inpermanent
medium and analysed with a Nikon microscope Eclipse 80i.
Statistical analysis
All experiments were performed in at least three independent
assays. A Wilcoxon test was used for comparison of immune cell
subpopulations in both types of decidua. A p-value of ,0.05 was
considered to be significant.
Supporting Information
Figure S1 Tissue sections of decidua basalis histocultures at
different culture time points. Structure and morphology of
histoculture explants was evaluated at day 0 (A), 3 (B), 6 (C), 10
(D), 14 (E), 18 (F) and 21 (G). Cell nuclei were stained with
haematoxylin (blue) and blood vessel structure was visualized on
tissue sections (black arrows). Necrotic zones appeared from day
18 (grey arrows). Pictures were taken at 6100 magnification and
the black scale-line represents 100 mm length.
Found at: doi:10.1371/journal.pone.0005971.s001 (9.36 MB TIF)
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